Damoctocog alfa pegol, sold under the brand name Jivi is a recombinant DNA-derived, Factor VIII concentrate used to treat hemophilia A. The most common side effects include headache, cough, nausea, and fever. Damoctocog alfa pegol was approved for medical use in the United States in August 2018, and in the European Union in November 2018.
Damoctocog alfa pegol, sold under the brand name Jivi is a recombinant DNA-derived, Factor VIII concentrate used to treat hemophilia A. The most common side effects include headache, cough, nausea, and fever. Damoctocog alfa pegol was approved for medical use in the United States in August 2018, and in the European Union in November 2018.
Source: Wikipedia "Damoctocog alfa pegol" · CC BY-SA 4.0
Share this article: X · Bluesky